#chirality

Episode 3: When Algorithms Miss the Mirror: How Chiral Blind Spots Break the Pipeline?

Leave a Comment / Chiral science / By / , , , / January 1, 2026

“When molecules have two hands but AI only sees one.” On Visuals and Stereochemical TruthSome illustrations in this series are generated or assisted by AI to support conceptual understanding. These visuals are intentionally simplified and should not be read as stereochemically rigorous or chemically exact representations. Wherever stereochemical fidelity matters, it is addressed explicitly in the discussion—because in chemistry, especially in chiral systems, intuition must always yield to structure. The first two parts of this …

Episode 3: When Algorithms Miss the Mirror: How Chiral Blind Spots Break the Pipeline? Read More »

Episode 2: Why Chirality Confuses Machines?

Leave a Comment / Chiral science / By / , , , , / December 29, 2025

“AI isn’t blind—just stereo-sloppy” On Visuals and Stereochemical TruthSome illustrations in this series are generated or assisted by AI to support conceptual understanding. These visuals are intentionally simplified and should not be read as stereochemically rigorous or chemically exact representations. Wherever stereochemical fidelity matters, it is addressed explicitly in the discussion—because in chemistry, especially in chiral systems, intuition must always yield to structure. The first episode argued that many AI models in drug discovery are …

Episode 2: Why Chirality Confuses Machines? Read More »

Episode 1: The Promise and the Paradox: AI That Miss the Mirror

Leave a Comment / Chiral science / By / , , , , / December 27, 2025

“When algorithms forget the mirror, molecules lose their meaning” On Visuals and Stereochemical TruthSome illustrations in this series are generated or assisted by AI to support conceptual understanding. These visuals are intentionally simplified and should not be read as stereochemically rigorous or chemically exact representations. Wherever stereochemical fidelity matters, it is addressed explicitly in the discussion—because in chemistry, especially in chiral systems, intuition must always yield to structure. Artificial intelligence is now everywhere in drug …

Episode 1: The Promise and the Paradox: AI That Miss the Mirror Read More »

Chiral Drug Engineering: Building Safer, Smarter, and More Selective Medicines

Leave a Comment / Chiral science / By / , , , , , / November 25, 2025

Where a molecule’s handedness meets clever engineering—shaping safer, more precise, and more effective medicines. Introduction: Why Chirality Matters in Drug Engineering In the world of drug design, a subtle twist in molecular geometry can change everything. Two molecules may share the same atoms and bonding pattern yet behave like entirely different substances simply because they are arranged as non-superimposable mirror images—enantiomers. This property, known as chirality, is one of the most critical yet nuanced dimensions …

Chiral Drug Engineering: Building Safer, Smarter, and More Selective Medicines Read More »

🧭 The Molecular Grammar of Medicines: Isomerism, Chirality, and Stereochemical Relationships Explained

Leave a Comment / Chiral science, Chirality, Drug stereochemistry, Stereochemistry / By / , , , , , / November 12, 2025

“Where molecules speak, stereochemistry gives them meaning“ In pharmaceuticals, structure is language — and stereochemistry is its grammar. The way atoms arrange in 3D space shapes how drugs work, how they are regulated, and how safe they are. This Chiralpedia tutorial simplifies the molecular “grammar” behind drug behavior and innovation. When Structure Speaks Every drug molecule has a story written in its structure. Two compounds may share the same formula yet act entirely differently due …

🧭 The Molecular Grammar of Medicines: Isomerism, Chirality, and Stereochemical Relationships Explained Read More »

The Hidden Chirality in Drug Metabolites: A metabolic blind spot

Leave a Comment / Chiral science, Chirality, Drug stereochemistry / By / , , , , / October 26, 2025

“Chirality isn’t hidden — we just stopped looking closely enough” The Unseen Journey After the Dose: 💊 When a patient swallows a drug, the journey is far from over. Sometimes, the real chiral story begins after the dose. The drug molecule meets a series of enzymes — oxidases, reductases, transferases — each capable of transforming it into one or more metabolites. We often assume these are simply inactive breakdown products, but chemistry rarely plays it …

The Hidden Chirality in Drug Metabolites: A metabolic blind spot Read More »

When Drug Labels Miss the Twist: The regulatory bind spot

Leave a Comment / Chiral Pharmacology, Chiral science, Chirality / By / , , , , , / October 24, 2025

“When chemistry tells two stories, the label should tell both” Drug labels tell us what’s inside — but not always how the molecule twists. And sometimes, that subtle twist changes everything: how a drug acts, how it’s regulated, and even whether it’s safe or addictive. Chirality — the property of handedness in molecules — has always shaped pharmacology. One mirror image of a molecule (an enantiomer) can save lives, while its twin may do little …

When Drug Labels Miss the Twist: The regulatory bind spot Read More »

Part 10: Stereochemistry in Pharmaceutical Sciences – Current Trends and Future Directions

Leave a Comment / Stereochemistry / By / , , / October 6, 2025

“Beyond today – emerging trends shaping the future of stereochemistry in pharma” Introduction The landscape of stereochemistry in pharmaceutical sciences continues to evolve with scientific and technological advances. This final part looks at emerging trends and future challenges. These include: – New developments in asymmetric catalysis, such as organocatalysts (MacMillan/List catalysts) that have expanded the toolkit for chiral synthesis, and the 2021 Nobel recognition of this field – implying more green and metal-free asymmetric processes …

Part 10: Stereochemistry in Pharmaceutical Sciences – Current Trends and Future Directions Read More »

Part 9: Stereochemistry in Drug Discovery and Development

Leave a Comment / Stereochemistry / By / , , / October 3, 2025

“From hit to lead to medicine – where stereochemistry shapes every stage of discovery” Introduction Stereochemistry is not only crucial in the final stages of drug production – it plays a significant role right from the discovery and lead optimization phases. In this part, we consider how medicinal chemists account for chirality when designing compounds and how structure-activity relationships (SAR) can depend on stereochemistry. We also look at how screening libraries incorporate stereochemical diversity, and …

Part 9: Stereochemistry in Drug Discovery and Development Read More »

Ibuprofen

Leave a Comment / Chiral Pharmacology, Chiral science / By / , , / September 29, 2025

Ibuprofen is a widely used non-steroidal anti-inflammatory drug (NSAID). It is a monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-(2-methylpropyl)phenyl group. Hence belongs to the propionic acid derivative class of NSAIDs. It is commonly prescribed for pain, inflammation, and fever. Available as over-the-counter (OTC) and prescription medication worldwide. Chirality and Biological Activity Structurally, Ibuprofen is a chiral molecule with one stereogenic center at the α-position …

Ibuprofen Read More »